Aimovig (Erenumab-Aooe) Drug Interactions: 1 Moderate
Aimovig (Erenumab-Aooe) Drug Interactions
Check all documented drug-to-drug interactions. Major, moderate, and minor interactions with descriptions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Aimovig. Always confirm against the full prescribing information.
100 interactions
Adalimumab
The risk or severity of adverse effects can be increased when Adalimumab is combined with Erenumab.
Level 2 evidence
Adenovirus type 7 vaccine live
The risk or severity of adverse effects can be increased when Erenumab is combined with Adenovirus type 7 vaccine live.
Level 2 evidence
Aducanumab
The risk or severity of adverse effects can be increased when Aducanumab is combined with Erenumab.
Level 2 evidence
Alemtuzumab
The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Erenumab.
Level 2 evidence
Alirocumab
The risk or severity of adverse effects can be increased when Alirocumab is combined with Erenumab.
Level 2 evidence
Amivantamab
The risk or severity of adverse effects can be increased when Erenumab is combined with Amivantamab.
Level 2 evidence
Anifrolumab
The risk or severity of adverse effects can be increased when Anifrolumab is combined with Erenumab.
Level 2 evidence
Ansuvimab
The risk or severity of adverse effects can be increased when Erenumab is combined with Ansuvimab.
Level 2 evidence
Anthrax immune globulin human
The risk or severity of adverse effects can be increased when Erenumab is combined with Anthrax immune globulin human.
Level 2 evidence
Anthrax vaccine
The risk or severity of adverse effects can be increased when Erenumab is combined with Anthrax vaccine.
Level 2 evidence
Antilymphocyte immunoglobulin (horse)
The risk or severity of adverse effects can be increased when Antilymphocyte immunoglobulin (horse) is combined with Erenumab.
Level 2 evidence
Antithymocyte immunoglobulin (rabbit)
The risk or severity of adverse effects can be increased when Antithymocyte immunoglobulin (rabbit) is combined with Erenumab.
Aimovig (Erenumab-Aooe) has 196 documented drug interactions. Always review the full list with a pharmacist before co-prescribing.
Aimovig (Erenumab-Aooe) has 0 major, 1 moderate, and 195 minor documented interactions.
A therapy excluded from this list does not necessarily mean no interaction exists between that therapy and Aimovig. Always confirm against the full prescribing information.